Problem with recalled antihypertensives may not be a new one
In August, we reported on what initially appeared to be a limited problem affecting certain lots of drugs containing valsartan, an angiotensin receptor blocker (ARB). Since then, however, manufacturers' troubles with this and similar drugs have mushroomed. In this article, we review what happened after those initial reports.